A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/407 (2006.01) A61K 31/438 (2006.01) A61P 25/04 (2006.01)
Patent
CA 2664702
The invention relates to the use of compounds having an affinity for the µ opioid receptor of at least 100 nM (Ki human value) and an affinity for the ORL-1 receptor for producing a medicament for treating pain, the ratio between the ORL1/µ affinities defined as 1/[Ki(ORL1)/Ki(µ)] being between 0.1 and 30.
L'invention concerne l'utilisation de composés qui présentent une affinité pour le récepteur opioïde µ d'au moins 100 nM (valeur Ki chez l'homme) et une affinité pour le récepteur ORL-1 pour produire un médicament contre la douleur, le rapport entre les affinités ORL1/µ représenté par 1/[Ki(ORL1)/Ki(µ)] étant compris entre 0,1 et 30.
Christoph Thomas
de Vry Jean
Friderichs Elmar
Koegel Babette-Yvonne
Linz Klaus
Fetherstonhaugh & Co.
Gruenenthal Gmbh
LandOfFree
Mixed orl1/mu-agonists for the treatment of pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mixed orl1/mu-agonists for the treatment of pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mixed orl1/mu-agonists for the treatment of pain will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2023365